
Priche Generics Private Limited
About Priche Generics Private Limited
Data last updated:
Priche Generics Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Glochem Industries Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 04 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2016PTC112294. Its GSTIN is 36AAICP8376K2ZN (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹8.5 Cr and a paid-up capital of ₹1.65 Cr. It is led by directors Subbarao Kattamuri and Sushma Kattamuri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G.V. Chambers 7 – 2 – C8 & C8/2 Ida Sanathnagar, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹96.36 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net profit of ₹21.23 Cr (net margin 22%) and EBITDA of ₹30.98 Cr (EBITDA margin 32.1%).
As per MCA filings, the company has open charges of ₹49.47 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Priche Generics Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG.V. Chambers 7 – 2 – C8 & C8/2 Ida Sanathnagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Priche Generics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Priche Generics is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Priche Generics Private Limited, buy the company report.
Financials of Priche Generics Private Limited
FY 2025 filings availablePriche Generics Private Limited reported revenue of ₹96.36 Cr (down 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year. EBITDA rose 206% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.98 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.1% | ||||
| Net Profit Margin | 22% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Priche Generics Private Limited, buy the company report.
Board of directors of Priche Generics Private Limited
Priche Generics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subbarao Kattamuri | Director | 04 Oct 2016 | 10 Years 1 Months | Current |
| Sushma Kattamuri | Director | 10 Aug 2024 | 2 Years 3 Months | Current |
Auditor
Priche Generics Private Limited is audited by RAJU SINGHVI & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJU SINGHVI & CO | FY 2019 | 015432S |
Shareholding
The shareholding of Priche Generics Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Priche Generics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 May 2022 | 100568534 | Hdfc Bank Limited | ₹37.47 Cr | Open | |
| 24 Jan 2001 | 90116056 | Others | ₹12 Cr | Open |
To see the full charge records of Priche Generics Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Priche Generics Private Limited has 2 court cases on record: 2 filed by Priche Generics. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Priche Generics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Priche Generics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Priche Generics has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICP8376K2ZN | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Priche Generics Private Limited, buy the company report.
Recent activity
Priche Generics Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Sushma Kattamuri ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Priche Generics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 04 October 2016 (10+ years old) and is registered under CIN U74999TG2016PTC112294.
Priche Generics has 2 current directors:
- Subbarao Kattamuri - Director
- Sushma Kattamuri - Director
The latest financial statements of Priche Generics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Priche Generics is 36AAICP8376K2ZN, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Priche Generics is U74999TG2016PTC112294. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Priche Generics has 2 court cases on record: 2 filed by the company.
Priche Generics was incorporated on 04 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sushma Kattamuri ceased to be Additional Director on 29 Sep 2024. Sundeep Kattamuri ceased to be Director on 10 Aug 2024. Sushma Kattamuri was appointed as Director on 10 Aug 2024. Priche Generics has 4 board changes on record in total.
The registered office of Priche Generics is at G.V. Chambers 7 – 2 – C8 & C82 Ida Sanathnagar, Hyderabad, Telangana, India – 500018.
Priche Generics operates in the pharma industry, in the pharma contract r and d segment.

